Expert Perspectives of a 67-Year-Old Man with Metastatic HER2+ Gastric Cancer

John Marshall, MD, reviews the case of a patient with metastatic HER2+ (human epidermal growth factor receptor 2) cancer of the gastroesophageal junction.